Brazil labels severe as "moderate" so they are the

Brazil labels severe as "moderate" so they are the same for our purposes. That trial has begun. Critical is a separate trial allowing IV administration. From what I understand, the critical trial passed ethical approval last Thursday so we should see an update within about ten days.